Pharmacoeconomics of three Therapeutic Schemes for Anti-tuberculosis Therapy Induced Liver Injury in China

  title={Pharmacoeconomics of three Therapeutic Schemes for Anti-tuberculosis Therapy Induced Liver Injury in China},
  author={Yu Chen and Peng Ye and Chong Kon Ren and Pengfei Ren and Zheng-Liang Ma and Lin Zhang and Wenliang Zhou and Chang-Jie Jiang},
  journal={Open Medicine},
  pages={53 - 63}
Abstract To evaluate the pharmacoeconomics of three therapeutic schemes in treating anti-tuberluosis therapy -induced liver injury (anti-TB DILI). Methods In the construction of a decision tree model, the efficacy and safety parameters came from the results of the randomized, controlled trial conducted here, the effect parameters were derived from expert advice, and the cost parameters, such as usage specification, number, and unit price, came from literature, expert advice, and so on. Results… 

Figures and Tables from this paper

Appropriate chemopreventive strategy for anti-tubercular therapy related liver injury is unsettled: Results from a systematic review and network meta-analysis
N-acetyl cysteine, but not Silymarin/Silibinin, appears to be beneficial in prevention of ATT-DILI, however, the results were limited by the possible risk of bias in included studies, variable definitions ofATT-DilI and limited number and category of patients.
Schisandra fruits for the management of drug-induced liver injury in China: A review.
Drug-Induced Liver Injury from Anti-Tuberculosis Treatment: A Retrospective Cohort Study
Female gender, combination therapy for antitubercular drugs (isoniazid, rifampicin and pyrazinamide), re-challenge were the risk factors associated with the severity of anti-TB DILI.
Pharmacotherapies for Drug-Induced Liver Injury: A Current Literature Review
The accumulated literature with evidence-based medicine researches for DILI in clinical practice was reviewed and the drawbacks of the clinical studies involved in the article, unmet needs and prospective development for DilI therapy were discussed.
Plant-based Food Products for Antimycobacterial Therapy
With early diagnosis and appropriate treatment most of the patients infected with TB can be successfully cured, however, 3.4% of new TB cases and 18% of previously treated cases had Rifampicin-resistant TB (RR-TB) or Multidrug- resistant TB (MDR-TB), which can be treated with significantly lower success rate.
A New 3D Cultured Liver Chip and Real-Time Monitoring System Based on Microfluidic Technology
The experimental results show that the liver chip and its monitoring system designed in this paper can maintain 100% cell viability of hepatocytes in vitro for a long time and can meet the requirements of measurement technologies such as electrical impedance measurement and near-infrared spectroscopy in real-time, providing a stable culture platform for the further study of organ chips.


Role of bicyclol in preventing drug-induced liver injury in tuberculosis patients with liver disease.
  • N. Chu, L. Li, H-P Xiao
  • Medicine, Biology
    The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease
  • 2015
Adding bicyclol to basic liver protectants may effectively and safely prevent the occurrence of anti-tuberculosis DILI in patients with underlying liver disease, and help simplify anti-Tuberculosis treatment.
An official ATS statement: hepatotoxicity of antituberculosis therapy.
Systematic steps for prevention and management of TB DILI are recommended, including patient and regimen selection to optimize benefits over risks, effective staff and patient education, ready access to care for patients, good communication among providers, and judicious use of clinical and biochemical monitoring.
[Effect of glycyrrhizin on anti-tuberculosis drug-induced hepatitis].
The time required for liver function normalization in the patients who received glycyrrhizin (SNMC, 40 ml daily, intravenously) was 15.1 +/- 4.5 days and the time required in the non-glycyr rhizin group was15.2 +/- 5.2 days, indicating that glycyRrhiz in is not useful for the treatment of anti-tuberculosis drug-induced hepatitis.
A cost effectiveness analysis of the preferred antidotes for acute paracetamol poisoning patients in Sri Lanka
Post ingestion time is an important determinant of preferred antidotal therapy for acute paracetamol poisoning patients in Sri Lanka and on economic grounds, methionine should become the preferred antidote for Sri Lankan patients treated within 10 hours of the acute ingestion and n-acetylcysteine should continue to be given to patients treating within 10-24 hours.
CSH guidelines for the diagnosis and treatment of drug-induced liver injury
The CSH guidelines summarized the epidemiology, pathogenesis, pathology, and clinical manifestation and gives 16 evidence-based recommendations on diagnosis, differential diagnosis, treatment, and prevention of DILI.
Isoniazid-induced liver injury and immune response in mice
A mouse model was developed of INH-induced liver injury in which the immune system appears to play a both protective and pathogenic role, but this study was unable to develop a model of InH- induced liver failure.
Protective effect of bicyclol on acute hepatic failure induced by lipopolysaccharide and D-galactosamine in mice.
Cost minimization analysis comparing enteral N-acetylcysteine to intravenous acetylcysteine in the management of acute acetaminophen toxicity
Patients who were treated with IV acetylcysteine had a decreased length of stay and cost of hospitalization compared with those patients who were treating with enteral acetylymsteine, indicating which treatment route is the most cost-effective.
Mechanism of protective action of bicyclol against CCl4‐induced liver injury in mice
The results suggest that bicyclol has remarkable hepatoprotective effects and its mechanism of action may be related to a decrease in free radical‐induced damage to hepatocytes.
Protective effect of bicyclol on acute alcohol-induced liver injury in mice.